No Data
No Data
Castle Biosciences (NASDAQ:CSTL) Is Using Debt Safely
DecisionDx-Melanoma Can Identify Melanoma Patients With Low Risk of Sentinel Lymph Node Positivity Who May Safely Forego Biopsy Surgery, New Independent Study Affirms
Insider Sale: COO Kristen Oelschlager Sells Shares of Castle Biosciences Inc (CSTL)
Express News | Castle Biosciences Announced Publication Of A New Study In Future Oncology Further Substantiating Use Of Its DecisionDx-SCC Test In Guiding Patient Selection And Decision-making Related To The Use Of Art In Patients With High-risk Cutaneous Squamous...
Express News | Study Confirms the Ability of Castle Biosciences' Decisiondx®-Scc Test to Predict Likelihood of Benefit From Adjuvant Radiation Therapy in Patients With High-Risk Cutaneous Squamous Cell Carcinoma
Study Confirms the Ability of Castle Biosciences' DecisionDx-SCC Test to Predict Likelihood of Benefit From Adjuvant Radiation Therapy in Patients With High-Risk Cutaneous Squamous Cell Carcinoma
No Data
No Data